Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 2, 2013
Patent Application Number
12086876
Date Filed
December 19, 2006
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
